WHO Pauses Hydroxychloroquine Medical Trials for COVID-19
The move comes after a report linked the drug to an increased fatality rate among those with coronavirus.
WHO halts malaria drug in COVID-19 trialsThe World Health Organization said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalized patients with..
Unsure Of Data, Study Authors Retract Lancet Article On HydroxychloroquineAn influential article in the British medical journal The Lancet found hydroxychloroquine increased the risk of death in COVID-19 patients. Now, three of its authors have retracted their study on..
'WHO should've researched independently’: CSIR welcomes HCQ trial resumptionCouncil of Scientific and Industrial Research (CSIR) welcomed WHO’s move to resume hydroxychloroquine trials. WHO on Thursday said HCQ will return to solidarity trial for potential treatment for..